XML 47 R37.htm IDEA: XBRL DOCUMENT v3.21.1
Basis of Presentation - Revision of Prior Period Financial Statements (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2021
Mar. 31, 2020
Sales:        
Total sales $ 14,088 $ 16,883 $ 25,476 $ 33,741
Cost of sales:        
Total cost of sales 9,720 12,400 17,730 25,227
Gross profit 4,368 4,483 7,746 8,514
Operating loss (121) (143) (658) (545)
Net loss $ (847) $ (732) $ 304 $ (1,272)
Net (loss) income per share – basic $ (0.20) $ (0.18) $ 0.07 $ (0.32)
Net (loss) income per share – diluted $ (0.20) $ (0.18) $ 0.07 $ (0.32)
Product        
Sales:        
Total sales $ 10,976 $ 13,146 $ 19,384 $ 26,705
Cost of sales:        
Total cost of sales 8,553 11,033 15,502 22,637
Service        
Sales:        
Total sales 3,112 3,737 6,092 7,036
Cost of sales:        
Total cost of sales $ 1,167 1,367 $ 2,228 2,590
As Reported        
Sales:        
Total sales   16,095   32,667
Cost of sales:        
Total cost of sales   11,612   24,153
Gross profit   4,483   8,514
Operating loss   (143)   (545)
Net loss   $ (732)   $ (1,272)
Net (loss) income per share – basic   $ (0.18)   $ (0.32)
Net (loss) income per share – diluted   $ (0.18)   $ (0.32)
As Reported | Product        
Sales:        
Total sales   $ 12,296   $ 25,518
Cost of sales:        
Total cost of sales   10,245   21,563
As Reported | Service        
Sales:        
Total sales   3,799   7,149
Cost of sales:        
Total cost of sales   1,367   2,590
Restatement Adjustment        
Sales:        
Total sales   788   1,074
Cost of sales:        
Total cost of sales   788   1,074
Restatement Adjustment | Product        
Sales:        
Total sales   850   1,187
Cost of sales:        
Total cost of sales   788   1,074
Restatement Adjustment | Service        
Sales:        
Total sales   $ (62)   $ (113)